Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Pharmaceuticals (Basel, Switzerland)
|
January 12, 2021
Drug Conjugated and Bispecific Antibodies for Multiple Myeloma: Improving Immunotherapies off the Shelf
Gregorio Barilà, Rita Rizzi, Renato Zambello, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
May 16, 2025
An Update of the Appropriate Sequencing for Salvage Therapies in Multiple Myeloma
Gregorio Barilà, Francesca Rezzonico, Laura Pavan, et al.
Frontiers in Immunology
|
March 12, 2014
Activating KIRs in Chronic Lymphoproliferative Disorder of NK Cells: Protection from Viruses and Disease Induction?
Renato Zambello, Antonella Teramo, Gregorio Barilà, et al.
Cells
|
April 5, 2020
NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias
Renato Zambello, Gregorio Barilà, Sabrina Manni, et al.
Frontiers in Oncology
|
June 6, 2020
Actionable Strategies to Target Multiple Myeloma Plasma Cell Resistance/Resilience to Stress: Insights From "Omics" Research
Sabrina Manni, Anna Fregnani, Gregorio Barilà, et al.
Blood Reviews
|
March 4, 2023
Not all LGL leukemias are created equal
Gianpietro Semenzato, Giulia Calabretto, Gregorio Barilà, et al.
Hemasphere
|
June 26, 2025
NK-type large granular lymphocyte leukemia comes of age
Gianpietro Semenzato, Antonella Teramo, Gregorio Barilà, et al.
Cells
|
October 23, 2021
Neutropenia and Large Granular Lymphocyte Leukemia: From Pathogenesis to Therapeutic Options
Giulia Calabretto, Antonella Teramo, Gregorio Barilà, et al.
Frontiers in Oncology
|
March 6, 2020
Insights Into Genetic Landscape of Large Granular Lymphocyte Leukemia
Antonella Teramo, Gregorio Barilà, Giulia Calabretto, et al.
Blood Cancer Journal
|
January 18, 2024
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders
Gianpietro Semenzato, Giulia Calabretto, Antonella Teramo, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Pharmaceuticals (Basel, Switzerland)
|
January 12, 2021
Drug Conjugated and Bispecific Antibodies for Multiple Myeloma: Improving Immunotherapies off the Shelf
Gregorio Barilà, Rita Rizzi, Renato Zambello, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
May 16, 2025
An Update of the Appropriate Sequencing for Salvage Therapies in Multiple Myeloma
Gregorio Barilà, Francesca Rezzonico, Laura Pavan, et al.
Frontiers in Immunology
|
March 12, 2014
Activating KIRs in Chronic Lymphoproliferative Disorder of NK Cells: Protection from Viruses and Disease Induction?
Renato Zambello, Antonella Teramo, Gregorio Barilà, et al.
Cells
|
April 5, 2020
NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias
Renato Zambello, Gregorio Barilà, Sabrina Manni, et al.
Frontiers in Oncology
|
June 6, 2020
Actionable Strategies to Target Multiple Myeloma Plasma Cell Resistance/Resilience to Stress: Insights From "Omics" Research
Sabrina Manni, Anna Fregnani, Gregorio Barilà, et al.
Blood Reviews
|
March 4, 2023
Not all LGL leukemias are created equal
Gianpietro Semenzato, Giulia Calabretto, Gregorio Barilà, et al.
Hemasphere
|
June 26, 2025
NK-type large granular lymphocyte leukemia comes of age
Gianpietro Semenzato, Antonella Teramo, Gregorio Barilà, et al.
Cells
|
October 23, 2021
Neutropenia and Large Granular Lymphocyte Leukemia: From Pathogenesis to Therapeutic Options
Giulia Calabretto, Antonella Teramo, Gregorio Barilà, et al.
Frontiers in Oncology
|
March 6, 2020
Insights Into Genetic Landscape of Large Granular Lymphocyte Leukemia
Antonella Teramo, Gregorio Barilà, Giulia Calabretto, et al.
Blood Cancer Journal
|
January 18, 2024
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders
Gianpietro Semenzato, Giulia Calabretto, Antonella Teramo, et al.
Page
of 5